GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Background In recent years new models of intraocular lenses are appearing on the market to reduce requirements for additional optical correction. The purpose of this study is to assess visual outcomes ...
Please provide your email address to receive an email when new articles are posted on . Among IOLs for presbyopia, trifocal options are gaining increasing appreciation. According to many users, ...
Trifocal intraocular lenses (IOLs) represent the latest in premium lens technology. They are tiny, artificial lenses that are implanted into the eye during a cataract or lens replacement procedure.
TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...
More than three million cataract surgeries performed in Europe annually[1] Basel, Switzerland, June 16, 2015 - Alcon, the global leader in eye care and a division of Novartis, has received European CE ...
Trifocal lenses correct three types of vision: close-up, intermediate, and distance. You may be more familiar with correction for distances far away and near, but you likely use your intermediate ...
Milestone strengthens the company’s leadership in advanced IOL innovation FINEVISION HP, with millions of implantations worldwide, will now be available to U.S. patients Proprietary design features ...
Jeffrey Horn, MD, of Nashville, Tenn.-based Vision for Life, will implant a PanOptix Trifocal Intraocular Lens in a patient Sept. 4. 1. Dr. Horn will complete what is believed to be the first ...
Intraocular lenses (IOL) used in modern cataract surgery have been designed to achieve a good quality of vision at near and intermediate distance as well as far. The FineVision® trifocal diffractive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results